Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country

BMC Public Health

Frank P Schelp³  Songsri Worawat¹  Mantana Trakulwong¹  Worawitaya Tawityanon¹  Pongdech Sarakarn⁴  Pattara Sanchaisuriya²  Benja Muktabhant² 

[1] Na Klang Hospital, Na Klang District, Nong Bua Lamphu Province, Thailand;Department of Nutrition, Faculty of Public Health, Khon Kaen University, 123 Mitharaphap Road, Khon Kaen, 40002, Thailand;Faculty of Public Health, Khon Kaen University, 123 Mitharaphap Road, Khon Kaen, 40002, Thailand;Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University, 123 Mitharaphap Road, Khon Kaen, 40002, Thailand

关键词: Middle income country;    HbA1c;    Screening;    Diabetes mellitus;   

Others  :  1163626
DOI  :  10.1186/1471-2458-12-349

 received in 2011-07-29, accepted in 2012-05-14,  发布年份 2012

【 摘 要 】

Background

Thailand is considered to be a middle income country, and to control and prevent type 2 diabetes mellitus (T2DM) is one of the main concerns of the Thai Ministry of Public Health (MoPH). Screening for T2DM and care for T2DM patients has been integrated into the primary health care system, especially in rural areas. The intention of this investigation is to link public health research at the academic level with the local health authorities of a district of a north-eastern province of the country.

Methods

Epidemiological methods were applied to validate the screening tools fasting capillary blood glucose (CBG), measured by glucometer and venous blood for the determination of plasma glucose (VPG), used for screening for T2DM among asymptomatic villagers. For assessing the validity of these two methods glycated haemoglobin (HbA1c) values were determined and used as the ‘clinical reference’.

Results

All together 669 villagers were investigated. Determinations of CBG and VPG resulted in suspected T2DM cases, with 7.3% when assessed by CBG and 6.4% by VPG using a cutoff point of 7 mmol/L (126 mg/dl). Taking HbA1c determinations with a cutoff point of 7% into account, the proportion of T2DM suspected participants increased to 10.4%. By estimating sensitivity, specificity and the positive predictive value of CBG and VPG against the ‘clinical reference’ of HbA1c, sensitivity below 50% for both screening methods has been observed. The positive predictive value was determined to be 58.5% for CBG and 56.8% for VPG. The specificity of the two screening tests was over 96%.

Conclusions

The low sensitivity indicates that using fasting CBG or VPG as a screening tool in the field results in a high proportion of diseased individuals remaining undetected. The equally low positive predictive values (below 60%) indicate a high working load for the curative sector in investigating suspected T2DM cases to determine whether they are truly diseased or false positive cases according to the screening method. Further implications of the results and the controversial discussion related to the use of HbA1c as clinical evidence for suffering from T2DM are also discussed.

【 授权许可】

   
2012 Muktabhant et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
• [2]WHO: Preventing chronic diseases: A vital investment. World Health Organization Press, Geneva; 2005.
• [3]Lawn JE, Rohde J, Rifkin S, Were M, Paul VK, Chopra M: Alma-Ata 30 years on: revolutionary, relevant, and time to revitalize. Lancet 2008, 372:917-927.
• [4]Rohde J, Cousens S, Chopra M, Tangcharoensathien V, Black R, Bhutta ZA, Lawn JE: 30 years after Alma-Ata: has primary health care worked in countries? Lancet 2008, 372:950-961.
• [5]Kruk ME, Porignon D, Rockers PC, Lerberghe WV WV: The contribution of primary care to health and health systems in low- and middle-income countries: A critical review of major primary care initiatives. Soc Sci Med 2010, 70:904-911.
• [6]Popkin BM, Horton SH, Kim S: The nutrition transition and prevention of diet-related diseases in Asia and the Pacific. Food Nutr Bull 2001, 22(Suppl 3):3-51.
• [7]MoPH: Thailand Health Profile Report, 2005-2007. Ministry of Public Health, Thailand; 2008.
• [8]Simmons RK, Unwin N, Griffin SJ: International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes. Diabetes Res Clin Pract 2010, 87:143-149.
• [9]Aekplakorn W, Stolk RP, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S, Woodward M: The prevalence and management of diabetes in Thai adults. Diabetes Care 2003, 26:2758-2763.
• [10]Aekplakorn W, Abbott-Klafter J, Premgamone A, Dhanamun B, Chaikittiporn C, Chongsuvivatwong V, Suwanprapisa T, Chaipornsupaisan W, Tiptaradolo S, Lim SS: Prevalence and management of diabetes and associated risk factors by regions of Thailand. Diabetes Care 2007, 30:2007-2012.
• [11]Chaisiri K, Pongpaew P, Tungtrongchitr R, Phonrat B, Kulleap S, Kuhathong C, Sutthiwong P, Intarakkao C, Mahaweerawat U, Khongdee W, Sanchaisuriya P, Saowakontha S, Merkle A, Schelp FP: Prevalence and abnormal glucose tolerance in Khon Kaen province and validity of urine stick and fasting blood sugar as screening tools. J Thai Med Assoc 1997, 80:363-371.
• [12]WHO: Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. World Health Organization Press, Geneva; 2006.
• [13]Nitiyanant W, Ploybutr S, Sriussadaporn S, Yamwong P, Vannasaeng S: Evaluation of the new fasting plasma glucose cutpoint of 7.0 mmol/l in detection of diabetes mellitus in the Thai population. Diabetes Res Clin Pract 1998, 41:171-176.
• [14]Koenig RJ, Ptereson CM, Kilo C, Cerami A, Williamson JR: Hemoglobin A1c as an indicator of the degree of glucose intolerance in diabetes. Diabetes 1976, 25:230-232.
• [15]Koening Rj, Petereson CM, Jones RL, Saudek C, Lehrman M, Cerami A: Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 1976, 295:417-420.
• [16]Wilson SE, Lipscombe LL, Rosella LC, Manuel DG: Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: A population based study. BMC Health Serv Res 2009, 9:41. BioMed Central Full Text
• [17]The International Expert Committee: International Expert Committee Report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
• [18]American Diabetes Association: Diagnosis criteria for diabetes mellitus. Diabetes Care 2010, 33(suppl 1):S62-S69.
• [19]Report of a World Health Organisation Consultation: Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2010.
• [20]Davidson MB, Schriger DL: Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: Implications for the diagnosis of diabetes. Diabetes Res Clin Pract 2010, 87:415-421.
• [21]New York City Department of Health and Mental Hygiene: The New York City A1c registry. http://www.nyc.gov/html/doh/html/diabetes/diabtes-nycar webcite. Accessed October 29, 2010
• [22]Paisooksantivatana K, Kongsomgan A, Leohirun L, Atamasirikul K, Kunakorn M: HemoglobinA1c level in healthy Thai adults: Reference interval and fasting plasma glucose. Diabetes Res Clin Pract 2009, 83:e43-e46.
• [23]Gomez-Perez FJ, Aguilar-Salinas CA, Almeda-Valdes P, Cuevas-Ramos D, Garber IL, Rull JA: Opinion. HbA1c for the diagnosis of diabetes mellitus in a developing country. A position article. Arch Med Res 2010, 41:302-308.
• [24]Inmuong U, Charerntanyarak L, Furu P: Community perceptions of health determinants in Khon Kaen Province, Thailand. Southeast Asian J Trop Med Public Health 2009, 40:380-391.
• [25]Reynolds TM, Twomey PJ, Hervey TC, Green BN: The number of unexpected HbA1c variants may be a greater problem in routine practice than is generally realized. Diabet Med 2004, 21:1041-1044.
• [26]Bleyer AJ, Hire D, Russell GB, Xu J, Divers J, Shihhabi Z, Bowden DW, Freedman BI: Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin. Diabet Med 2009, 26:128-133.
• [27]Likhari T, Gama R: Glycaemia-independent ethnic differences in HbA1c in subjects with impaired glucose tolerance. Diabet Med 2009, 26:1068-1069.
• [28]Christensen DL, Witte DR, Kaduka L, Jorgensen ME, Borch-Johnsen K, Mohan V, Shaw JE, Tabak AG, Vistisen D: Moving to an A1c-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010, 33:580-582.
• [29]Herman WH: Do race and ethnicity impact hemoglobin A1c independent of glycemia? J Diabetes Sci Technol 2009, 3:656-660.
• [30]Weatherall DJ, Clegg JB: Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001, 79:704-712.
• [31]Fucharoen S, Winichagoon P: Thalassemia in Southeast Asia: problem and strategy for prevention and control. Southeast Asian J Trop Med Public Health 1992, 23:647-655.
• [32]Sanchaisuriya K, Fucharoen S, Ratanasiri T, Sanchaisuriya P, Fucharoen G, Dietz E, Schelp FP: Effect of the maternal beta E- globulin gene on hematologic responses to iron supplementation during pregnancy. Am J Clin Nutr 2007, 85:474-479.
• [33]Sirichotiyakul S, Tantipalakorn C, Sanguansermsri T, Wanapirak C, Tongsong T: Erythrocyte osmotic fragility test for screening of aalpha-thalassemia-1 and beta-thalassemia trait in pregnancy. Int J Gynaecol Obstet 2004, 86:347-350.
• [34]Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM: Tests of glycemia in diabetes. Diabetes Care 1995, 18:896-909.
• [35]Paisooksantivatana K, Kongsomgan A, Banyatsuppasin W, Khupulsup K: Influence of hemoglobin E on measurement of hemoglobin A1c by immunoassays. Diabetes Res Clin Pract 2009, 83:e84-e85.
• [36]Krovesdy CP, Sharma K, Kalantar-Zadeh K: Glycemic control in diabetic CKD patients: where do we stand? Am J Kidney Dis 2008, 52:766-777.
• [37]Aekplakorn W, Srivanichakorn S, Sangwatanaroj S: Microalbuminuria and metabolic risk factors in patients with type 2 diabetes in primary care settings in Thailand. Diabetes Res Clin Pract 2009, 84:92-98.
• [38]Fajans SS, Herman WH, Oral EA: Insufficient sensitivity of haemoglobin A1c determination in diagnosis or screening of early diabetic states. Metabolism 2011, 60:86-91.
• [39]Srivanichakorn S, Sukpordee N, Yana T, Sachchaisuriya P, Schelp FP: Health status of diabetes type2 patients in Thailand contradicts their perception and admitted compliance. Prim Care Diabetes 2011, 5:195-201.